Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07684469 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07684469 · ClinicalTrials.gov record · last posted 2026-07-06

Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia

Name: Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia — clinical trial record (NCT07684469)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 4

SponsorNovartis Pharmaceuticals

Started2026-06-30

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This study aims to evaluate the effectiveness and safety of implementing a systematic augmented low-density lipoprotein cholesterol (LDL-C) management care pathway initiated in hospitals for patients with Acute Coronary Syndrome. This pathway includes treatment with inclisiran on top of the standard of care (SOC), which consists of statins with or without ezetimibe, compared to a high-intensity SOC regimen alone (statins +/- ezetimibe).

Trial Details

NCT Number	NCT07684469
Lead Sponsor	Novartis Pharmaceuticals
Conditions	Acute Coronary Syndrome
Enrollment	300 participants
Start Date	2026-06-30
Primary Completion	2027-02-28 (estimated)
Study Completion	2028-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-06